.Basilea Pharmaceutica's job developing brand-new antifungals has gotten a significant improvement f...
.Having already gathered up the USA legal rights to Capricor Therapies' late-stage Duchenne muscle d...
.After dismissing the choice date for Applied Therapeutics' metabolic condition medication govoresta...
.Novo Nordisk is actually proceeding its own press in to hereditary medicines, accepting to compensa...
.Innovent Biologics has actually produced the situation that its checkpoint inhibitor-cytokine combi...
.A stage 3 test of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC) h...
.5 months after Rakovina Rehabs rotated towards artificial intelligence, the cancer-focused biotech ...
.Ascendis Pharma has actually emerged as a potential danger to BioMarin's Voxzogo, reporting period ...
.Though Alkeus Pharmaceuticals' dental eye disease property stopped working to dramatically reduce g...
.With a trio of biotechs striking the Nasdaq on Friday, it was actually very easy to overlook a smal...
.Immune system gate preventions are the superheroes of cancer cells treatment. Drugs like Bristol My...
.Welcome to this week's Chutes & Ladders, our roundup of significant management hirings, firings ...
.Regeneron is back with lasting consequence for its LAG-3 prevention and also PD-1 prevention combo ...
.AstraZeneca has shared a very early look at the performance of its internal antibody-drug conjugate...
.After revealing a stage 3 launch based upon good midstage end results, iTeos and GSK are eventually...
.The FDA needs to be actually much more available and collective to release a surge in approvals of ...
.It is actually an extraordinarily hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX a...
.Atea Pharmaceuticals' antiviral has actually fallen short another COVID-19 test, but the biotech st...
.Neurocrine Biosciences' mental illness system pivot has actually failed. The biotech was incapable ...
.Sanofi has actually brought in an overdue access to the radioligand celebration, paying out one hun...